LABORATORIOS CERO LTDA. – Trademark Portfolio

Entity Type: 03

LABORATORIOS CERO LTDA. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CERO. The owner is based in Medellin.

Calle 12 sur No. 50G-21

Medellin , CO

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CERO
CERO
Registered 1996

Trademark Classifications

LABORATORIOS CERO LTDA.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does LABORATORIOS CERO LTDA. have?

LABORATORIOS CERO LTDA. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does LABORATORIOS CERO LTDA. file in?

LABORATORIOS CERO LTDA. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are LABORATORIOS CERO LTDA.'s most well-known trademarks?

LABORATORIOS CERO LTDA.'s registered trademark portfolio includes well-known marks such as CERO. These are among 1 currently registered trademark in the portfolio.

What is LABORATORIOS CERO LTDA.'s trademark registration success rate?

LABORATORIOS CERO LTDA. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.